Events

Hematological Malignancies Update for Primary Care Providers

Intended Audience

The intended audience for this conference includes primary care physicians. Fellows, residents, physician assistants, advanced practice nurses, oncology nurses, cancer registrars, and other physicians with an educational need or interest in this topic may also attend.

Overall Learner Objectives

At the completion of this course, participants will be able to:

• Identify new methods for the diagnosis of hematological malignancies

• Describe new therapies, in particular those that patients use at home, their efficacy, and side effects

• Describe the long term effects of therapy for hematological malignancies

Brochure

Click here to download the complete brochure with information about faculty, agenda, accreditation, refund policy and more. (PDF)

Accreditation/Designation/Disclosure

The Cooper Health System is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Cooper Health System takes responsibility for the content, quality, and scientific integrity of this CME activity.

The Cooper Health System designates this live activity for a maximum of 2 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of one hour of a continuing medical education (CME) course recognized by the American Medical Association, the American Osteopathic Association, or the American Podiatric Medical Association is equal to one hour of continuing education for New Jersey nursing license renewal (New Jersey Board of Nursing 13:37-5.3).

Note: Fees include course syllabus, continental breakfasts, refreshment breaks, and luncheons.

Need More Information?

Please contact Continuing Medical Education at (856) 382-6480 or email CME@cooperhealth.edu.